Pulmatrix, Inc. (PULM)

Pulmatrix Statistics

Total Valuation

Pulmatrix has a market cap or net worth of $18.59 million. The enterprise value is $12.77 million.

Market Cap	18.59M
Enterprise Value	12.77M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, before market open.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Pulmatrix has 3.65 million shares outstanding.

Current Share Class	3.65M
Shares Outstanding	3.65M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	9.17%
Float	3.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	50.38
Forward PS	n/a
PB Ratio	3.32
P/TBV Ratio	3.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	34.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.21

Current Ratio	11.21
Quick Ratio	10.63
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -83.85% and return on invested capital (ROIC) is -52.83%.

Return on Equity (ROE)	-83.85%
Return on Assets (ROA)	-45.62%
Return on Invested Capital (ROIC)	-52.83%
Return on Capital Employed (ROCE)	-142.83%
Revenue Per Employee	$184,500
Profits Per Employee	-$3.97M
Employee Count	2
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +153.23% in the last 52 weeks. The beta is 1.57, so Pulmatrix's price volatility has been higher than the market average.

Beta (5Y)	1.57
52-Week Price Change	+153.23%
50-Day Moving Average	5.32
200-Day Moving Average	6.55
Relative Strength Index (RSI)	51.54
Average Volume (20 Days)	9,714

Short Selling Information

The latest short interest is 7,294, so 0.20% of the outstanding shares have been sold short.

Short Interest	7,294
Short Previous Month	9,830
Short % of Shares Out	0.20%
Short % of Float	0.20%
Short Ratio (days to cover)	0.66

Income Statement

In the last 12 months, Pulmatrix had revenue of $369,000 and -$7.93 million in losses. Loss per share was -$2.17.

Revenue	369,000
Gross Profit	-484,000
Operating Income	-8.00M
Pretax Income	-8.85M
Net Income	-7.93M
EBITDA	-7.95M
EBIT	-8.00M
Loss Per Share	-$2.17

Balance Sheet

The company has $5.83 million in cash and n/a in debt, giving a net cash position of $5.83 million or $1.59 per share.

Cash & Cash Equivalents	5.83M
Total Debt	n/a
Net Cash	5.83M
Net Cash Per Share	$1.59
Equity (Book Value)	5.60M
Book Value Per Share	1.53
Working Capital	5.59M

Cash Flow

Operating Cash Flow	-8.02M
Capital Expenditures	n/a
Free Cash Flow	-8.02M
FCF Per Share	-$2.19

Margins

Gross Margin	-131.17%
Operating Margin	-2,169.11%
Pretax Margin	-2,149.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pulmatrix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-42.66%
FCF Yield	-43.12%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Pulmatrix has an Altman Z-Score of -51.28 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-51.28
Piotroski F-Score	1